JP2021519321A5 - - Google Patents
Info
- Publication number
- JP2021519321A5 JP2021519321A5 JP2020552234A JP2020552234A JP2021519321A5 JP 2021519321 A5 JP2021519321 A5 JP 2021519321A5 JP 2020552234 A JP2020552234 A JP 2020552234A JP 2020552234 A JP2020552234 A JP 2020552234A JP 2021519321 A5 JP2021519321 A5 JP 2021519321A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- pharmaceutical composition
- approximately
- peptide
- aqueous pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862648746P | 2018-03-27 | 2018-03-27 | |
| US62/648,746 | 2018-03-27 | ||
| PCT/US2019/024331 WO2019191264A1 (en) | 2018-03-27 | 2019-03-27 | Peptide-containing formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519321A JP2021519321A (ja) | 2021-08-10 |
| JP2021519321A5 true JP2021519321A5 (https=) | 2022-03-31 |
Family
ID=66103053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552234A Abandoned JP2021519321A (ja) | 2018-03-27 | 2019-03-27 | ペプチド含有製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11517608B2 (https=) |
| EP (1) | EP3773627A1 (https=) |
| JP (1) | JP2021519321A (https=) |
| KR (1) | KR20200139723A (https=) |
| CN (1) | CN112040958A (https=) |
| AU (1) | AU2019243724A1 (https=) |
| CA (1) | CA3097341A1 (https=) |
| IL (1) | IL277466A (https=) |
| MX (1) | MX2020010085A (https=) |
| TW (1) | TW202002996A (https=) |
| WO (1) | WO2019191264A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113876929B (zh) * | 2021-11-22 | 2024-02-23 | 中国人民解放军陆军军医大学 | 肽MOTS-c在制备治疗帕金森药物中的应用 |
| CN115444926A (zh) * | 2022-05-10 | 2022-12-09 | 江南大学 | MOTS-c肽及其衍生物在制备放射性肺损伤治疗药物中的应用 |
| CN118236470A (zh) * | 2024-03-29 | 2024-06-25 | 无锡市第二人民医院 | MOTS-c肽及其衍生物在制备支气管哮喘治疗药物中的应用 |
| CN119241659B (zh) * | 2024-10-08 | 2025-09-19 | 西北大学 | MOTS-c及其氨基酸突变多肽在伤口愈合方面的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001076532A2 (en) | 2000-04-11 | 2001-10-18 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| US8309525B2 (en) | 2007-05-30 | 2012-11-13 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof |
| CN101827610A (zh) | 2007-06-29 | 2010-09-08 | 森托科尔奥索生物科技公司 | 抗mcp-1抗体、组合物、方法和用途 |
| US7998928B2 (en) | 2007-09-14 | 2011-08-16 | The Regents Of The University Of California | Method of treatment of type-1 diabetes with a humanin analogue |
| US8637470B2 (en) | 2008-05-01 | 2014-01-28 | The Regents Of The University Of California | Small humanin-like peptides |
| WO2012009709A1 (en) | 2010-07-16 | 2012-01-19 | Sudhir Paul | Hiv cd4 binding site based covalent immunogen compositions |
| US20130123168A1 (en) | 2011-06-17 | 2013-05-16 | The Regents Of The University Of California | Humanin and humanin-analogues for the management of atherosclerosis |
| US20140296139A1 (en) | 2013-03-15 | 2014-10-02 | The Regents Of The University Of California | Mitochondrial-derived peptide mots3 regulates metabolism and cell survival |
| CA3038292A1 (en) * | 2016-09-28 | 2018-04-05 | Cohbar, Inc. | Therapeutic mots-c related peptides |
-
2019
- 2019-03-27 EP EP19717170.5A patent/EP3773627A1/en not_active Withdrawn
- 2019-03-27 CA CA3097341A patent/CA3097341A1/en active Pending
- 2019-03-27 MX MX2020010085A patent/MX2020010085A/es unknown
- 2019-03-27 CN CN201980026908.0A patent/CN112040958A/zh active Pending
- 2019-03-27 JP JP2020552234A patent/JP2021519321A/ja not_active Abandoned
- 2019-03-27 AU AU2019243724A patent/AU2019243724A1/en not_active Abandoned
- 2019-03-27 WO PCT/US2019/024331 patent/WO2019191264A1/en not_active Ceased
- 2019-03-27 KR KR1020207030897A patent/KR20200139723A/ko not_active Withdrawn
- 2019-03-27 TW TW108110719A patent/TW202002996A/zh unknown
- 2019-03-27 US US16/981,870 patent/US11517608B2/en active Active
-
2020
- 2020-09-21 IL IL277466A patent/IL277466A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519321A5 (https=) | ||
| CN102274492B (zh) | 骨合成代谢蛋白质的药物递送方法 | |
| JP3295430B2 (ja) | グルカゴンを含んでなる医薬製剤 | |
| CN102718858B (zh) | 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用 | |
| JPH02101022A (ja) | 糖尿病治療用医薬組成物 | |
| JP2002544241A (ja) | 生体活性剤の改良された細胞取り込み | |
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| TW201127395A (en) | Pharmaceutical composition comprising a GLP-1 agonist and methionine | |
| JP2022502432A5 (https=) | ||
| TW201105346A (en) | Heat-stable and vibration-stable insulin preparations | |
| CN102727861A (zh) | T-细胞介导的疾病的治疗 | |
| ES2324009B1 (es) | Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo. | |
| US20140371141A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
| CN110087666A (zh) | 用于治疗糖尿病、高血压和高胆固醇血症的组合物和方法 | |
| JP2014515747A (ja) | 医薬組成物 | |
| JP2023500032A5 (https=) | ||
| ES2952519T3 (es) | Polipéptidos cíclicos, su procedimiento de obtención y su aplicación en terapéutica | |
| CN102133200B (zh) | 一种人类松弛素-2 Relaxin的注射用冻干粉制剂 | |
| AU2009218060B2 (en) | Pharmaceutical composition for transnasal administration | |
| CN101671390A (zh) | 人干扰素α衍生物及其聚乙二醇化修饰物的制备和用途 | |
| JP2009528303A5 (https=) | ||
| CN108339116B (zh) | 壬二酸的应用、含有壬二酸的佐剂和疫苗剂 | |
| Wen | Advances and challenges in the dosage form design for the treatment of Parkinson’s disease | |
| JPH05170664A (ja) | 安定なペプチド医薬組成物 | |
| CN108025042A (zh) | PTHrP类似物的新型制剂 |